Primary Record
Prostratin
- In stock
- 4,518 g
- Purity
- 98.9 %
- CAS
- 60857-08-1
Compound Identifiers & Properties
- CAS
- 60857-08-1
- PubChem CID
- 454217
- SMILES
- C[C@@H]1C[C@@]2([C@@H](C2(C)C)[C@H]3[C@]1([C@@H]4C=C(C(=O)[C@]4(CC(=C3)CO)O)C)O)OC(=O)C
- Canonical SMILES
- CC(=O)O[C@@]12C[C@@H](C)[C@@]3(O)[C@@H](C=C(CO)C[C@]4(O)C(=O)C(C)=C[C@@H]34)[C@@H]1C2(C)C
Names & Synonyms
- Prostratin
- Trigowiin A
- 12-Deoxyphorbol 13-acetate
- 12-Deoxyphorbol-13-acetate
- Stillingia Factor S7
- 60857-08-1
- Prostatin >99%
- 13-O-Acetylphorbol
- Prostratin & Mukungulu
- AC1L9RHH
- RefChem:930087
- KO94U6DIQ6
- CCRIS 6292
- SCHEMBL344837
- DTXSID10893788
- SA-101A
- CHEMBL170518
- orb1705054
- C22H30O6
- Prostratin, >=98% (HPLC)
- CHEBI:69818
- BOJKFRKNLSCGHY-HXGSDTCMSA-N
- BOJKFRKNLSCGHY-MVVYQSCENA-N
- K-101A
- DTXCID401323833
- GLXC-02539
- HMS3648K03
- NSC 623310
- NSC-623310
- ZINC3915682
- 2017AH
- BDBM50368315
- CID454217
- MFCD00674138
- NSC623310
- 13-O-ACETYL-12-DEOXYPHORBOL
- AKOS027250797
- C22-H30-O6
- CCG-208192
- CID:454217
- SMP2_000144
- NCGC00343958-02
- 12-deoxyphorbol-13-acetate (prostratin)
- DA-66943
- J19.621E
- MS-26507
- SID:313389835
- HY-107421
- CS-0028449
- C20197
- G91401
- C070999
- NSC 623310; SA 101A; Stillingia factor S7
- SR-01000946228
- A1204369
- Q3270742
- SR-01000946228-1
- BRD-K91145395-001-01-9
- [dihydroxy-(hydroxymethyl)-tetramethyl-oxo-[?]yl] acetate
- B1370-145032
- (1aR,1bS,4aR,7aS,7bR,8R,9aS)-9a-(Acetyloxy)-1,1a,1b,4,4a,7a,7b,8,9,9a-decahydro-4a,7b-dihydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-5H-cyclopropa[3,4]benz[1,2-e]azulen-5-one
- (1aR,1bS,4aR,7aS,7bR,8R,9aS)-4a,7b-dihydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-5-oxo-1,1a,1b,4,4a,5,7a,7b,8,9-decahydro-9aH-cyclopropa[3,4]benzo[1,2-e]azulen-9a-yl acetate
- [(1R,2S,6R,10S,11R,13S,15R)-1,6-dihydroxy-8-(hydroxymethyl)-4,12,12,15-tetramethyl-5-oxo-13-tetracyclo[8.5.0.02,6.011,13]pentadeca-3,8-dienyl] acetate
- ((1R,2S,6R,10S,11R,13S,15R)-1,6-dihydroxy-8-(hydroxymethyl)-4,12,12,15-tetramethyl-5-oxo-13-tetracyclo(8.5.0.02,6.011,13)pentadeca-3,8-dienyl) acetate
- (1aR)-1,1,6,8alpha-Tetramethyl-3-(hydroxymethyl)-4abeta,7balpha-dihydroxy-9aalpha-acetoxy-1,1aalpha,1bbeta,4,4a,7aalpha,7b,8,9,9a-decahydro-5H-cyclopropa[3,4]benzo[1,2-e]azulene-5-one
- (1aR)-1,1aalpha,1bbeta,4,4a,7aalpha,7b,8,9,9a-Decahydro-4abeta,7balpha-dihydroxy-9aalpha-acetoxy-3-(hydroxymethyl)-1,1,6,8alpha-tetramethyl-5H-cyclopropa[3,4]benzo[1,2-e]azulene-5-one
- (1aR)-9aalpha-Acetoxy-1,1aalpha,1bbeta,4,4a,7aalpha,7b,8,9,9a-decahydro-4abeta,7balpha-dihydroxy-3-hydroxymethyl-1,1,6,8alpha-tetramethyl-5H-cyclopropa[3,4]benz[1,2-e]azulen-5-one
- (1aR,1bS,4aR,7aS,7bR,8R,9aS)-9a-(Acetyloxy)-1,1a,1b,4,4a,7a,7b,8,9,9a -decahydro-4a,7b-dihydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl- 5H-cyclopropa[3,4]benz[1,2-e]azulen-5-one
- (1AR,1BS,4AR,7AS,7BR,8R,9AS)-9A-(ACETYLOXY)-1,1A,1B,4,4A,7A,7B,8,9,9A-DECAHYDRO-4A,7B-DIHYDROXY-3-(HYDROXYMETHYL)-1,1,6,8-TETRAMETHYL-5H-CYCLOPROPA(3,4)BENZ(1,2-E)AZULEN-5-ONE
- (1R,2S,6R,10S,11R,13S,15R)-1,6-dihydroxy-8-(hydroxymethyl)-4,12,12,15-tetramethyl-5-oxotetracyclo[8.5.0.02,6.011,13]pentadeca-3,8-dien-13-yl acetate
- 4a,7b-Dihydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-5-oxo-1,1a,1b,4,4a,5,7a,7b,8,9-decahydro-9aH-cyclopropa[3,4]benzo[1,2-e]azulen-9a-yl acetate
- 5H-CYCLOPROPA(3,4)BENZ(1,2-E)AZULEN-5-ONE, 9A-(ACETYLOXY)-1,1A,1B,4,4A,7A,7B,8,9,9A-DECAHYDRO-4A,7B-DIHYDROXY-3-(HYDROXYMETHYL)-1,1,6,8-TETRAMETHYL-, (1AR,1BS,4AR,7AS,7BR,8R,9AS)-
- 5H-CYCLOPROPA(3,4)BENZ(1,2-E)AZULEN-5-ONE, 9A-(ACETYLOXY)-1,1A,1B,4,4A,7A,7B,8,9,9A-DECAHYDRO-4A,7B-DIHYDROXY-3-(HYDROXYMETHYL)-1,1,6,8-TETRAMETHYL-, (1AR-(1A.ALPHA.,1B.BETA.,4A.BETA.,7A.ALPHA.,7B.ALPHA.,8.ALPHA.,9A.ALPHA.))-
- 5H-Cyclopropa[3,4]benz[1,2-e]azulen-5-one,9a-(acetyloxy)-1,1a,1b,4,4a,7a,7b,8,9,9a-decahydro-4a,7b-dihydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-,(1aR,1bS,4aR,7aS,7bR,8R,9aS)-